GlucoTrack

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlucoTrack and other ETFs, options, and stocks.

About GCTK

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. 

CEO
Erik Emerson
CEOErik Emerson
Employees
15
Employees15
Headquarters
Rutherford, New Jersey
HeadquartersRutherford, New Jersey
Founded
2001
Founded2001
Employees
15
Employees15

GCTK Key Statistics

Market cap
1.98M
Market cap1.98M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
125.08K
Average volume125.08K
High today
$2.55
High today$2.55
Low today
$2.39
Low today$2.39
Open price
$2.39
Open price$2.39
Volume
27.65K
Volume27.65K
52 Week high
$136.29
52 Week high$136.29
52 Week low
$2.18
52 Week low$2.18

Stock Snapshot

As of today, GlucoTrack(GCTK) shares are valued at $2.49. The company's market cap stands at 1.98M, with a P/E ratio of -0.01.

On 2026-09-20, GlucoTrack(GCTK) stock moved within a range of $2.39 to $2.55. With shares now at $2.49, the stock is trading +4.1% above its intraday low and -2.4% below the session's peak.

Trading volume for GlucoTrack(GCTK) stock has reached 27.65K, versus its average volume of 125.08K.

The stock's 52-week range extends from a low of $2.18 to a high of $136.29.

The stock's 52-week range extends from a low of $2.18 to a high of $136.29.

GCTK News

Investing.com 2d
Glucotrack director Paul V. Goode resigns citing potential conflict of interest - Investing.com

...

Glucotrack director Paul V. Goode resigns citing potential conflict of interest - Investing.com
TipRanks 2d
GlucoTrack Director Resigns Amid Merger Conflict Concerns

An update from GlucoTrack ( (GCTK) ) is now available. On September 14, 2026, Glucotrack, Inc. announced that director Paul V. Goode resigned from its Board of...

TipRanks 6d
GlucoTrack Amends Warrant Terms Pending Shareholder Approval

GlucoTrack ( (GCTK) ) has issued an update. On August 4, 2026, GlucoTrack entered a private placement with an investor, issuing pre-funded warrants and common...

People also own

Based on the portfolios of people who own GCTK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.